First Ever Point-of-Care Instrument to Test for Fentanyl Receives FDA Clearance

March 8, 2023

Greensboro, NC (March 8, 2023) – Shenzhen Superbio Technology Co., LTD. (Superbio) has received clearance from the US Food and Drug Administration (FDA) on the first ever point-of-care instrument intended for qualitative detection of fentanyl in... Read more »

Carolina Liquid Chemistries Corp. and Diazyme Laboratories, Inc. Announce Partnership Expanding Test Menu on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer, Adding 25 New Assays Totaling Over 45 CLIA Categorized Assays

January 20, 2023

GREENSBORO, NC — (Jan. 20, 2023) – Carolina Liquid Chemistries Corp. (CLC) and Diazyme Laboratories, Inc. (Diazyme) announce a partnership to expand the test menu on the Diazyme DZ-Lite™ c270 benchtop clinical chemistry analyzer. Diazyme,... Read more »